200 related articles for article (PubMed ID: 37656348)
1. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
Vena A; Bassetti M; Mezzogori L; Marchesi F; Hoenigl M; Giacobbe DR; Corcione S; Bartoletti M; Stemler J; Pagano L; Cornely OA; Salmanton-García J
Infection; 2024 Feb; 52(1):197-208. PubMed ID: 37656348
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
Fernandes R; Sabino R; Cunha C; Cornely OA; Carvalho A; Salmanton-García J;
Mycopathologia; 2024 Jan; 189(1):15. PubMed ID: 38265528
[TBL] [Abstract][Full Text] [Related]
3. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
[TBL] [Abstract][Full Text] [Related]
4. The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
Salmanton-García J; Hoenigl M; Salzer HJF; Lackner M; Prattes J; Dichtl K; Winkler-Zamani M; Krause R; Stemler J; Lass-Flörl C; Cornely OA; Willinger B
Mycoses; 2023 Dec; 66(12):1056-1063. PubMed ID: 37592370
[TBL] [Abstract][Full Text] [Related]
5. The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).
Salmanton-García J; Au WY; Hoenigl M; Chai LYA; Badali H; Basher A; Brockhoff RA; Chen SC; Chindamporn A; Chowdhary A; Heath CH; Jabeen K; Lee J; Matar M; Taj-Aldeen SJ; Tan BH; Uno K; Wahyuningsih R; Zhu L; Chakrabarti A; Cornely OA
Int J Antimicrob Agents; 2023 Mar; 61(3):106718. PubMed ID: 36640851
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
Kovács R; Majoros L; Stemler J; Cornely OA; Salmanton-García J
Ther Adv Infect Dis; 2023; 10():20499361231219315. PubMed ID: 38116297
[TBL] [Abstract][Full Text] [Related]
7. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.
Salmanton-García J; Hoenigl M; Gangneux JP; Segal E; Alastruey-Izquierdo A; Arikan Akdagli S; Lagrou K; Özenci V; Vena A; Cornely OA
Lancet Microbe; 2023 Jan; 4(1):e47-e56. PubMed ID: 36463916
[TBL] [Abstract][Full Text] [Related]
8. The Argentinian landscape of mycological diagnostic capacity and treatment accessibility.
Riera F; Caeiro JP; Cornely OA; Salmanton-García J;
Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37312404
[TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
10. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.
Tan BH; Chakrabarti A; Patel A; Chua MMM; Sun PL; Liu Z; Rotjanapan P; Li R; Wahyuningsih R; Chayakulkeeree M; Chen YC;
Int J Infect Dis; 2020 Jun; 95():471-480. PubMed ID: 31945491
[TBL] [Abstract][Full Text] [Related]
11. Changes in the epidemiological landscape of invasive mould infections and disease.
Lass-Flörl C; Cuenca-Estrella M
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of invasive fungal diseases in pediatric patients.
Pana ZD; Vikelouda K; Roilides E
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1203-1213. PubMed ID: 27681004
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
Bassetti M; Vena A; Bouza E; Peghin M; Muñoz P; Righi E; Pea F; Lackner M; Lass-Flörl C
Clin Microbiol Infect; 2020 Aug; 26(8):1024-1033. PubMed ID: 32120042
[TBL] [Abstract][Full Text] [Related]
14. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
15. [Enlightenment of World Health Organization fungal priority pathogens list].
Liu W; Li RY
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Dec; 44(12):1984-1987. PubMed ID: 38129157
[TBL] [Abstract][Full Text] [Related]
16. Performance of Targeted Fungal Sequencing for Culture-Independent Diagnosis of Invasive Fungal Disease.
Gomez CA; Budvytiene I; Zemek AJ; Banaei N
Clin Infect Dis; 2017 Nov; 65(12):2035-2041. PubMed ID: 29020284
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).
Ruhnke M; Behre G; Buchheidt D; Christopeit M; Hamprecht A; Heinz W; Heussel CP; Horger M; Kurzai O; Karthaus M; Löffler J; Maschmeyer G; Penack O; Rieger C; Rickerts V; Ritter J; Schmidt-Hieber M; Schuelper N; Schwartz S; Ullmann A; Vehreschild JJ; von Lilienfeld-Toal M; Weber T; Wolf HH
Mycoses; 2018 Nov; 61(11):796-813. PubMed ID: 30098069
[TBL] [Abstract][Full Text] [Related]
18. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
Rogers TR; Verweij PE; Castanheira M; Dannaoui E; White PL; Arendrup MC;
J Antimicrob Chemother; 2022 Jul; 77(8):2053-2073. PubMed ID: 35703391
[TBL] [Abstract][Full Text] [Related]
20. [Invasive fungal infection over the last 30 years].
Silva JT; Ruiz-Camps I; Aguado JM
Rev Iberoam Micol; 2021; 38(2):47-51. PubMed ID: 34294520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
